Sarah D Berry1, Sebastian G Placide2, Elizabeth Mostofsky3, Yuqing Zhang4, Lewis A Lipsitz5, Murray A Mittleman3, Douglas P Kiel5. 1. Division of Gerontology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts. Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts. SarahBerry@hsl.harvard.edu. 2. Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts. 3. Department of Medicine, Beth Israel Deaconess Medical Center Cardiovascular Epidemiology Research Unit, Boston, Massachusetts. 4. Section of Preventive Medicine and Epidemiology, Boston University School of Medicine, Boston, Massachusetts. 5. Division of Gerontology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts. Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts.
Abstract
BACKGROUND: Psychotropic drugs increase the risk of falls, but they are still frequently prescribed to treat behavioral symptoms associated with dementia in the nursing home. We examined whether there is an acute increased risk of falls in the days following a change to an antipsychotic or benzodiazepine drug prescription. METHODS: We collected information on 594 long-stay nursing home residents from two facilities who fell at least once between September 1, 2010 and May 31, 2013. Psychotropic drug changes were ascertained from the facilities' computerized medication administration log. We used the case-crossover design to compare the frequency of antipsychotic and benzodiazepine drug changes during the days before a fall with the frequency of drug changes at more remote times. RESULTS: Mean age was 87.5 years, and 75.1% were female. The risk of falls was higher in the 24 hours following benzodiazepine initiation compared with other times (odds ratio [OR] 3.79, 95% confidence interval [CI] 1.10, 13.00). There was no clear difference in risk following antipsychotic initiation (OR 2.42, CI 0.58, 10.06), but this could be due to the small sample size. Stopping a benzodiazepine was associated with a significantly reduced fall risk (OR 0.26, 95% CI 0.08-0.91). CONCLUSIONS: Benzodiazepines pose an immediate threat to fall risk, whereas it is less clear if antipsychotics also pose an immediate risk. Nursing home staff should be particularly vigilant in the days following the new prescription for a benzodiazepine in an effort to prevent injury.
BACKGROUND: Psychotropic drugs increase the risk of falls, but they are still frequently prescribed to treat behavioral symptoms associated with dementia in the nursing home. We examined whether there is an acute increased risk of falls in the days following a change to an antipsychotic or benzodiazepine drug prescription. METHODS: We collected information on 594 long-stay nursing home residents from two facilities who fell at least once between September 1, 2010 and May 31, 2013. Psychotropic drug changes were ascertained from the facilities' computerized medication administration log. We used the case-crossover design to compare the frequency of antipsychotic and benzodiazepine drug changes during the days before a fall with the frequency of drug changes at more remote times. RESULTS: Mean age was 87.5 years, and 75.1% were female. The risk of falls was higher in the 24 hours following benzodiazepine initiation compared with other times (odds ratio [OR] 3.79, 95% confidence interval [CI] 1.10, 13.00). There was no clear difference in risk following antipsychotic initiation (OR 2.42, CI 0.58, 10.06), but this could be due to the small sample size. Stopping a benzodiazepine was associated with a significantly reduced fall risk (OR 0.26, 95% CI 0.08-0.91). CONCLUSIONS: Benzodiazepines pose an immediate threat to fall risk, whereas it is less clear if antipsychotics also pose an immediate risk. Nursing home staff should be particularly vigilant in the days following the new prescription for a benzodiazepine in an effort to prevent injury.
Authors: Maartje H de Groot; Jos P C M van Campen; Marije A Moek; Linda R Tulner; Jos H Beijnen; Claudine J C Lamoth Journal: Drugs Aging Date: 2013-11 Impact factor: 3.923
Authors: Krista F Huybrechts; Kenneth J Rothman; Rebecca A Silliman; M Alan Brookhart; Sebastian Schneeweiss Journal: CMAJ Date: 2011-03-28 Impact factor: 8.262
Authors: Le T T Hien; Robert G Cumming; Ian D Cameron; Jian S Chen; Stephen R Lord; Lyn M March; Jennifer Schwarz; David G Le Couteur; Philip N Sambrook Journal: J Am Geriatr Soc Date: 2005-08 Impact factor: 5.562
Authors: Melissa Koehler; Terry Rabinowitz; John Hirdes; Michael Stones; G Iain Carpenter; Brant E Fries; John N Morris; Richard N Jones Journal: BMC Geriatr Date: 2005-01-01 Impact factor: 3.921
Authors: Michael B Rothberg; Shoshana J Herzig; Penelope S Pekow; Jill Avrunin; Tara Lagu; Peter K Lindenauer Journal: J Am Geriatr Soc Date: 2013-04-30 Impact factor: 7.538
Authors: Ryan M Silwanowicz; Donovan T Maust; Lisa S Seyfried; Claire Chiang; Claire Stano; Helen C Kales Journal: Int J Geriatr Psychiatry Date: 2016-10-04 Impact factor: 3.485
Authors: Iosief Abraha; Joseph M Rimland; Fabiana Mirella Trotta; Giuseppina Dell'Aquila; Alfonso Cruz-Jentoft; Mirko Petrovic; Adalsteinn Gudmundsson; Roy Soiza; Denis O'Mahony; Antonio Guaita; Antonio Cherubini Journal: BMJ Open Date: 2017-03-16 Impact factor: 2.692
Authors: Marja-Liisa Dahl; Karin Leander; Max Vikström; Clara Frumerie; Sofia Nordenmalm; Jette Möller; Karin Söderberg-Löfdal Journal: Sci Rep Date: 2021-03-11 Impact factor: 4.379
Authors: Vanja Milosevic; Aimee Linkens; Bjorn Winkens; Kim P G M Hurkens; Dennis Wong; Brigit P C van Oijen; Hugo M van der Kuy; Carlota Mestres-Gonzalvo Journal: BMJ Open Date: 2021-05-03 Impact factor: 2.692
Authors: Marco Solmi; Andrea Murru; Isabella Pacchiarotti; Juan Undurraga; Nicola Veronese; Michele Fornaro; Brendon Stubbs; Francesco Monaco; Eduard Vieta; Mary V Seeman; Christoph U Correll; André F Carvalho Journal: Ther Clin Risk Manag Date: 2017-06-29 Impact factor: 2.423